Metabiomed

059210 · KOSDAQ · Health Care · SMALL CAP

Updated terms.

Metabiomed updated its declared cash dividend of US$0.07 per share, equal to about 2.1% of the recent share price.

Dividend([Amended] Cash/in-kind dividend decision)· FILED 2026-03-24· RCEPT 20260324901232

US$0.07Per share
2.1%vs. recent share price
US$1.91MTotal payout

Converted at 1 USD ≈ ₩1,485.36 (filing-date rate, 2026-03-24 close)

What happened

Metabiomed updated its declared cash dividend of US$0.07 per share, equal to about 2.1% of the recent share price.

For context, the filing sizes this payout at about 2.1% of the recent share price. That covers this declaration only, not an annualized rate.

Per shareUS$0.07
vs. recent share price2.1%
Total payoutUS$1.91M
Filed2026-03-24, [Amended] Cash/in-kind dividend decision
SourceDART rcept 20260324901232 → open original filing

Versions of this filing

  1. 2026-03-16Original
  2. 2026-03-24Amendment 1 (this page)

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-03-24 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.